Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
Saba Sayari, Hassan Neishaboori, Maryam Jameshorani
Clin Mol Hepatol. 2018;24(3):331-338. Published online 2018 Jun 12 DOI: https://doi.org/10.3350/cmh.2018.0006
Citations to this article as recorded by
Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
Yong Kyun Cho
Clinical and Molecular Hepatology.2018; 24(3): 299. CrossRef
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
Matteo Tacelli, Ciro Celsa, Bianca Magro, Aurora Giannetti, Grazia Pennisi, Federica Spatola, Salvatore Petta
Pharmaceuticals.2018; 11(4): 121. CrossRef